Loading…

A phase I/II multicenter, open-label, dose escalation and randomized trial of BI 836858 in patients with low- or intermediate-1-risk myelodysplastic syndrome

Saved in:

Bibliographic Details
Published in:	Haematologica (Roma) 2022-11, Vol.107 (11), p.2742-2747
Main Authors:	Komrokji, Rami S, Carraway, Hetty E, Germing, Ulrich, Wermke, Martin, Zeidan, Amer M, Fu, Eric, Rüter, Björn, Burkard, Ute, Osswald, Annika, Foran, James M
Format:	Article
Language:	English
Subjects:	Antibodies, Monoclonal, Humanized Dose-Response Relationship, Drug Humans Immunoglobulin Fc Fragments Letter to the Editor Myelodysplastic Syndromes Treatment Outcome
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!